Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NKGen Biotech ( (NKGN) ) has shared an update.
On September 18, 2025, NKGen Biotech, Inc. entered into a Stock Purchase Agreement with Asia Advisors Limited to sell 10,000,000 shares of common stock at $0.25 per share, totaling $2,500,000. The agreement includes warrants for an additional 20,000,000 shares and an option for Asia Advisors Limited to purchase more shares within a year. This move, made under exemptions from the Securities Act, could potentially impact NKGen Biotech’s financial structure and market positioning by providing significant capital and involving Asia Advisors in a business advisory role.
More about NKGen Biotech
Average Trading Volume: 65,781
Technical Sentiment Signal: Sell
Current Market Cap: $4.94M
For detailed information about NKGN stock, go to TipRanks’ Stock Analysis page.